As we wait for approval of LL for S/C and EUA, can we

New Post Public Reply Private Reply Replies (0) Message Board
Cassandra X
752
As we wait for approval of LL for S/C and EUA, can we recalibrate our thinking on what SHOULD happen in the fight against Sars2 with Leronlimab?

As far as we can tell, now or for the foreseeable future, there is nothing that will fight Sars2 better than Leronlimab, not in the S/C stage, not in Mild to Moderate, not at first detection of infection and even before infection. Why? Because nothing else resets our immune system to homeostasis. At that point, you are potentially as healthy as you are ever going to get.

If you have comorbidities, your immune system will work on those. If you are relatively without comorbidities, your immune system is ready to fully respond to any insults. We don't know how long homeostasis lasts for sure but evolution has probably tried to maintain this condition naturally.

It will last at least until it is challenged in a major way. How your body is left after a major battle with an infection or injury will impact your ability to respond to the next insult. What components of your immune system are over or under expressed?

Sars2 is not the only morbidity that can leave you with problems in the "long haul." This, I believe, is what explains the surprising illness in seemingly random younger people and the expected illness in older people with "experienced" immune systems. Your individual medical history is what determines how you will cope with Sars2 or other medical insults.

This suggests to me that anytime a person has a serious illness, their immune system should be "tuned up." How do you do that? With a dose of Leronlimab!

Can you see where I am going with this?

Let's work backwards, shall we? If you are S/C, what should you get? LL! If you are Moderate to Mild, what should you get? LL! If you have just tested positive for Sars2, what should you get? LL! If you have not yet been infected with LL, what should you get? LL! What if you have just been ill or injured, what should you get? LL!

There is no better health-state to be in than with a topped-up immune system! That is the point!

Gottlieb and the CEO of Moderna are now putting out the word that we may never be rid of Sars2. What does that mean? It means the virus will be out there in our environment like the common cold, mutating and infecting us potentially over and over again.

What will be the result of that? WITHOUT LERONLIMAB, deaths certainly, and a whole lot of messed-up people. Only the uninfected can expect to live healthy lives. Those who get infected and don't die but progress to the point of lung damage and microclots will live compromised lives. Even with LL, this damage can not be repaired. The long hauler studies will show what level of health and "normalcy" can be restored.

Those who are uninfected, especially as they grow older, are just waiting their turn! Those who were asymptomatic the first time they are infected likely will not be so lucky the second time. These are the potentially "messed-up" people. LIVING WITH THIS VIRUS WILL BE HELL!

What about social normalcy? Will we ever be able to take off our masks, ever be able to hug again, ever eat in restaurants again, ever have large family gatherings again? Probably not unless we defeat this virus.

How have viruses been defeated in the past? Viruses vary in communicability. Sars2 is one of the worst and may prove to be the worst. Viruses can disappear if they can no longer find hosts. Some that fail to find human host can find refuge in animal populations and infect humans again, like with Ebola.

The worst viruses may disappear after they have killed off too many their hosts, human and animal, to keep going. Hosts may be whittled down until some develop some sort of immunity like with those who have the CCR5 delta32 gene.

Going forward, modern medicine will work on drugs with different Mechanisms of Action that may do the virus in or some solution involving genetic engineering.

But for now, Leronlimab will soon prove itself to be the tallest tree in the forest. Vaccines have yet to prove they have staying power and they do not restore the immune system. Leronlimab is not a band-aid fix. It can fix many, many other health problems, too.

So the saddest part of Leronlimab's story going forward is that the quantities needed by the world will not be produced for a long time. That is the top priority for getting out of Pandemic Hell!









CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

European Flavors: A Halloween Food Revolution

Updated Category News Views 0

Who would've thought Halloween would toss a spin on fine dining? What's usually known for candy corn and spooky costumes has teamed up with European flavors for a night unlike any other. And we're talking more than just trick-or-treating here, folks. A New Kind of Halloween Spread This year, The Charming Taste of Europe has thrown itself into the Halloween festivities,...

Continue Reading
CAR T-Cell Therapy Offers New Hope for SPS Patients

Updated Category News Views 3

Game-changing Developments in CAR T-Cell Therapy Leaping straight into the meat of it—our friends at the University of Colorado Anschutz are onto something big. They've wrapped up a study pushing the boundaries of CAR T-cell therapy, and let me tell you, it looks like a real game-changer for those battling the rare beast known as stiff person syndrome (SPS). Breaking...

Continue Reading
Martha Stewart Joins SelectBlinds for Home Makeovers

Updated Category News Views 1

Iconic Collaboration: SelectBlinds and Martha Stewart Out in Chandler, Arizona, something interesting's stirring up the home decor scene—SelectBlinds teamed up with Martha Stewart to roll out a snazzy new collection of window treatments. Fix your eyes on The Martha Stewart Collection, debuting on October 20. It's bringing a shot of elevated elegance into your humble...

Continue Reading
Axis Fabrication Kicks Off New High-Tech Facility

Updated Category News Views 1

Axis Fab Unveils a Cutting-edge Hub No shortcuts here, folks. Axis Fabrication & Machine is rolling out the red carpet on November 4, 2026, to flaunt their brand-new 78,000-square-foot manufacturing beast in Rockford, Tennessee. We're talking about a $24 million bet on the future—a clear signal Axis is doubling down on the surge of industrial dynamism sweeping East...

Continue Reading
ManpowerGroup to Feature at J.P. Morgan Conference

Updated Category News Views 0

ManpowerGroup Heads to the Big Apple ManpowerGroup's top brass are packing their bags for New York City, heading to the J.P. Morgan Ultimate Services Investor Conference. Now, this isn’t just another cookie-cutter investor meet-up. Jack McGinnis, the CFO, and Becky Frankiewicz, the President and Chief Strategy Officer, are slated to have a fireside chat on November 17,...

Continue Reading
Certification Boosts Aviation Capital's Boeing 737-10 Prospects

Updated Category News Views 12

Nothing like a green light from the FAA to put a little extra swagger in an aircraft lessor's step, and that's exactly what's happening with Aviation Capital Group (ACG) and their big bet on Boeing's 737-10. It's like the champagne just got popped! This milestone is no minor hurdle. We're talking about the largest addition to the 737 MAX family finally giving an official...

Continue Reading
Digital Health Excellence: 14 Systems Earn Top Honors

Updated Category News Views 6

The pace at which healthcare is embracing digital transformation makes one's head spin these days. Fourteen organizations just hit the jackpot of sorts—the 2026 CHIME Digital Health Most Wired survey awarded them the highest honor, Level 10. This ain't just some participation trophy; it's the real deal, putting a spotlight on organizations that aren't merely dabbling in...

Continue Reading
Scrutinizing M&A Deals: VREX, HZO, SYNA Under Fire?

Updated Category News Views 20

Alignment or Deception: The M&A Alarm Bells Investors, strap in, because the world of mergers and acquisitions is lighting up like a pinball machine, and today's spotlight's on Varex Imaging Corporation (NASDAQ: VREX), MarineMax (NYSE: HZO), and Synaptics Incorporated (NASDAQ: SYNA). Halper Sadeh LLC, known for their tenacity in championing shareholder rights, has brought...

Continue Reading
Home Remodeling: Stages, Setbacks, and Strategies

Updated Category News Views 5

Home Remodeling: More Than Just a Facelift Ah, the prospect of turning your house into your dream home—sounds idyllic until you're knee-deep in dusty chaos. Remodeling isn't a walk in the park; it's a marathon filled with pitfalls and rollercoaster emotions. According to Brian Ward from Ward Construction & Remodeling, the process has set stages, and knowing these can...

Continue Reading
Advancing Mental Health in NICU Families: 2026 Event Insight

Updated Category News Views 4

Addressing Critical Needs: Hand to Hold's Mission Now, I don't know about you, but when I hear "NICU," my mind goes straight to the intense pressure and emotional rollercoaster that it signifies for families. Hand to Hold, a nonprofit that’s knee-deep in supporting NICU families, isn’t just sitting on their hands. They're hosting a 2026 National NICU Mental Health...

Continue Reading

Top 5 Most Recently Viewed Articles

ICEYE Expands Satellite Capabilities for Defence Operations

Updated Category News Views 160

ICEYE and Finnish Defence Forces Sign Agreement The ongoing enhancements in intelligence and surveillance capabilities are crucial for modern military forces. In a recent move to bolster these capabilities, the Finnish Defence Forces has entered into an agreement with ICEYE to acquire synthetic aperture radar (SAR) satellites. Details of the Acquisition Agreement This...

Continue Reading
HWH International Inc. Unveils Innovative Hapi Marketplace

Updated Category News Views 31

Introducing Hapi Marketplace: A New Era of Online Shopping HWH International Inc. is excited to unveil its latest innovation, the Hapi Marketplace, a unique business-to-consumer online shopping platform. This initiative is designed to provide consumers with a wide array of affordable, high-quality products catering to various lifestyle needs. The launch of Hapi...

Continue Reading
StoneX Enhances Wealth Management Services for Latin America

Updated Category News Views 294

StoneX Expands Wealth Management Services StoneX Group Inc. (NASDAQ: SNEX), a leading global financial services firm, has taken a significant step forward by acquiring Intercam Advisors, Inc. and Intercam Securities, Inc. This strategic move enhances StoneX’s capacity to provide comprehensive brokerage and investment advisory services specifically tailored for Latin...

Continue Reading
Guggenheim Investments Releases Insightful Credit Outlook

Updated Category News Views 95

Guggenheim Investments Shares Q4 2024 Credit Market Insights Guggenheim Investments has recently provided a comprehensive outlook on the high-yield bond and leveraged loan markets for the fourth quarter of 2024. This analysis offers valuable insights, especially in light of the recent Federal Reserve interest rate cuts, which are expected to influence leveraged credit...

Continue Reading
Charter Communications Elevates Adam Ray to Lead Spectrum Enterprise

Updated Category News Views 105

Adam Ray Takes Charge of Spectrum Enterprise at Charter In a significant move within the telecommunications industry, Charter Communications, Inc. (NASDAQ: CHTR) has appointed Adam Ray as the overseer of Spectrum Enterprise, a division boasting nearly $3 billion in operations. This decision comes as Bill Archer, a respected 35-year veteran in telecommunications and...

Continue Reading